Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV003337900 | SCV004048316 | likely pathogenic | Glanzmann thrombasthenia 2 | criteria provided, single submitter | clinical testing | The frameshift deletion p.Leu599HisfsTer3 in ITGB3 (NM_000212.3) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Leu599HisfsTer3 variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation caused a frameshift mutation. The p.Leu599HisfsTer3 variant is a loss of function variant in the gene ITGB3, which is intolerant of Loss of Function variants. For these reasons, this variant has been classified as Likely Pathogenic. |